|
Non-vitamin K oral anticoagulant (NOAC) Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Apixaban, Dabigatran, Edoxaban, Rivaroxaban
Los Angeles, California1 trial
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
Cedars-Sinai Medical Center
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.